Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C(44)Mab-34, for Multiple Applications against Oral Carcinomas

Cluster of differentiation 44 (CD44) has been investigated as a cancer stem cell (CSC) marker as it plays critical roles in tumor malignant progression. The splicing variants are overexpressed in many carcinomas, especially squamous cell carcinomas, and play critical roles in the promotion of tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Hiroyuki, Ozawa, Kazuki, Tanaka, Tomohiro, Kaneko, Mika K., Kato, Yukinari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136282/
https://www.ncbi.nlm.nih.gov/pubmed/37189717
http://dx.doi.org/10.3390/biomedicines11041099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136282/
https://www.ncbi.nlm.nih.gov/pubmed/37189717
http://dx.doi.org/10.3390/biomedicines11041099

Ejemplares similares